1) N-[(2'-Cyano-(1,1'-biphenyl)-4-yl)methyl)]valine methyl ester
缬沙坦烃化物
2) valsartan
缬沙坦
1.
Effect of valsartan on expression of receptor for advanced glycation end-products in renal tissues of diabetic rats;
缬沙坦对糖尿病大鼠肾组织糖化终末产物受体表达的影响
2.
Effects of Valsartan on myocardial Collagen remodeling and ASK1 protein expression after myocardial infarction in the rat heart;
缬沙坦对心肌梗死大鼠心肌胶原重塑、ASK1的影响
3.
Effect of valsartan on serum interleukin-6,tumor necrosis factor-alpha in diabetic nephropathy patients;
缬沙坦对糖尿病肾病患者血清IL-6和TNF-α水平的影响
3) Valsarta
缬沙坦
1.
Clinical Study of Hypertension with Left Ventricular Hypertrophy Treated by Valsarta with Amlodipine;
缬沙坦联合氨氯地平治疗原发性高血压左心室肥厚
2.
Influence of valsarta capsule on the function of the vascular endothelium in elderly patients with hypertension;
缬沙坦胶囊对老年高血压患者血管内皮功能的影响
3.
Objective To study the effects of valsarta combined with atorvastatin on intima-media thickness(IMT)of common carotid artery of patients with mild to moderate essential hypertension.
①目的比较观察缬沙坦联合阿托伐他汀应用与单用对原发性高血压病人颈动脉内膜中层厚度(IMT)的影响及临床意义。
4) benazepril
缬沙坦
1.
Comparative study on the effect of valsartan and benazepril on left ventricle thickening and myocardial fibrosis resulting from hypertension;
缬沙坦与苯那普利对高血压患者心肌纤维化及左室肥大逆转作用的对比研究
2.
The effects of Benazepril and Volsartan on brachial artery flow-mediated dilation dysfunction patients with hypertension;
缬沙坦和贝那普利对高血压患者肱动脉流量介导的舒张功能的干预作用
3.
Objective To investigate the effects of combined use of Valsartan and Benazepril on NF-κB in glomeruli of diabetic rats,and study their possible mechanisms.
方法实验动物随机分为五组:正常对照组(NC组)、糖尿病组(DM组)、缬沙坦治疗组(V组)、苯那普利治疗组(B组)、联合治疗组(V+B组),每组8只。
6) Diovan
代文,缬沙坦
补充资料：缬沙坦烃化物
分子式：C20H22N2O2
分子量：322.41
CAS号：137863-89-9
性质：密度1.12。
分子量：322.41
CAS号：137863-89-9
性质：密度1.12。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条